ArticlePharmacogenetics and genomics2025

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.

Nia Covington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.